NIHR Greater Manchester Patient Safety Translational Research Centre, NIHR School for Primary Care Research, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester M13 9PL, UK
NIHR Greater Manchester Patient Safety Translational Research Centre, NIHR School for Primary Care Research, Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester M13 9PL, UK.
BMJ. 2019 Jul 17;366:l4185. doi: 10.1136/bmj.l4185.
To systematically quantify the prevalence, severity, and nature of preventable patient harm across a range of medical settings globally.
Systematic review and meta-analysis.
Medline, PubMed, PsycINFO, Cinahl and Embase, WHOLIS, Google Scholar, and SIGLE from January 2000 to January 2019. The reference lists of eligible studies and other relevant systematic reviews were also searched.
Observational studies reporting preventable patient harm in medical care. The core outcomes were the prevalence, severity, and types of preventable patient harm reported as percentages and their 95% confidence intervals. Data extraction and critical appraisal were undertaken by two reviewers working independently. Random effects meta-analysis was employed followed by univariable and multivariable meta regression. Heterogeneity was quantified by using the I statistic, and publication bias was evaluated.
Of the 7313 records identified, 70 studies involving 337 025 patients were included in the meta-analysis. The pooled prevalence for preventable patient harm was 6% (95% confidence interval 5% to 7%). A pooled proportion of 12% (9% to 15%) of preventable patient harm was severe or led to death. Incidents related to drugs (25%, 95% confidence interval 16% to 34%) and other treatments (24%, 21% to 30%) accounted for the largest proportion of preventable patient harm. Compared with general hospitals (where most evidence originated), preventable patient harm was more prevalent in advanced specialties (intensive care or surgery; regression coefficient b=0.07, 95% confidence interval 0.04 to 0.10).
Around one in 20 patients are exposed to preventable harm in medical care. Although a focus on preventable patient harm has been encouraged by the international patient safety policy agenda, there are limited quality improvement practices specifically targeting incidents of preventable patient harm rather than overall patient harm (preventable and non-preventable). Developing and implementing evidence-based mitigation strategies specifically targeting preventable patient harm could lead to major service quality improvements in medical care which could also be more cost effective.
系统地量化全球各种医疗环境中可预防的患者伤害的发生率、严重程度和性质。
系统评价和荟萃分析。
从 2000 年 1 月至 2019 年 1 月,检索了 Medline、PubMed、PsycINFO、Cinahl 和 Embase、WHOLIS、Google Scholar 和 SIGLE。还检索了合格研究的参考文献列表和其他相关系统评价。
报告医疗保健中可预防的患者伤害的观察性研究。核心结果是报告的可预防患者伤害的发生率、严重程度和类型,以百分比及其 95%置信区间表示。数据提取和关键评估由两名独立工作的审查员进行。采用随机效应荟萃分析,然后进行单变量和多变量荟萃回归。使用 I 统计量量化异质性,并评估发表偏倚。
在 7313 条记录中,有 70 项研究涉及 337025 名患者,纳入荟萃分析。可预防的患者伤害发生率为 6%(95%置信区间为 5%至 7%)。可预防的患者伤害中严重或导致死亡的比例为 12%(9%至 15%)。与药物(25%,95%置信区间为 16%至 34%)和其他治疗相关的事件(24%,21%至 30%)占可预防的患者伤害的最大比例。与大多数证据来源的综合医院相比,在高级专科(重症监护或手术)中,可预防的患者伤害更为普遍(回归系数 b=0.07,95%置信区间为 0.04 至 0.10)。
大约每 20 名患者中就有 1 名在医疗保健中受到可预防的伤害。尽管国际患者安全政策议程鼓励关注可预防的患者伤害,但针对可预防的患者伤害而不是针对整体患者伤害(可预防和不可预防)的质量改进实践有限。开发和实施针对可预防的患者伤害的循证缓解策略可能会导致医疗保健服务质量的重大改进,并且可能更具成本效益。